, projected to reach $14 Billion in 2014, is fragmented with more than 500 companies, where 98% of them could benefit from the best practices of supply chain management. Molecular diagnostic tools have a vast base of end-users, which includes hospital-based laboratories, reference laboratories, and others (physicians’ labs, research laboratories, other healthcare clinics, and government agencies. The research will highlight the opportunities to achieve low product cost, high quality, compliance with governmental regulations, speed to market and customer service.
Mike Crowell, Sr. Director, Supply Chain Management, Verinata Health (Illumina)
Alan Wells, Vice President, Diagnostics Lab Operations, Life Technologies
PANEL: “Molecular Diagnostics Testing: Opportunities for SCM Efficiency!”
As scientists discover how to glean useful information from the human genome through sequencing and make that information clinically meaningful, this market will continue to grow rapidly from startup through to commercialization. These constituent would probably relish the opportunity to share the SCM tools and strategies used in this area. As you may know, the needs of a molecular diagnostic companies’ supply chains are just as critical to its success as it is to a larger pharma/biopharma commercial organization, but in many respects the strategies that are emerging are different from big pharma, or biopharma’ s needs (think a service delivery model supply chain vs. that of a drug manufacturer or distributor).
Moderator: Alan Wells, Vice President, Diagnostics Lab Operations, Life Technologies
Panelists: Glen McHenry, Sr., Manager, Supply Chain Group, Monogram Biosciences
Susan Jiang, Supply Chaing Supervisor, VErinata Health, Inc., (an Illumina company)
Karel Hurka, Jr., Sr. Manager Supply Chaing, Genomic Health
Case Study: “Managing Your 3-PL Partner"
Now that you have selected a part
Page: 1 2 3 4 5 6 7 8 Related biology technology :1
Copyright©2012 Vocus, Inc.
All rights reserved
. Fourth Annual U.S. Symposium at JASIS Organized by Pittcon’s Amit Ghosh and Koichiro Matsuda (Horiba)2
. BIOPHARMA Executives Summit, 6th BSMA Annual Conference: Look Who Is Confirmed to Speak3
. India Bioinformatics Industry Market Size Expected to Grow by Average Annual Growth of 14.4% in the Next 5 Years: Ken Research4
. Dennis R. Hill, MD to be a Panelist at the Third Annual Prostate Cancer Symposium Focusing on the Changing Paradigm of Prostate Cancer5
. GW Pharmaceuticals to Present at the 33rd Annual Canaccord Genuity Growth Conference6
. HOLLOWAY AMERICA to Feature Custom Steel Fabrication Products and Capabilities at the ISPE San Diego Chapter 21st Annual Vendor Night Exhibit Show7
. MiMedx To Present At 33rd Annual Canaccord Genuity Growth Conference8
. Biotech & BioPharma Professionals: CA Board of Pharmacy Executive, Virginia Herold, to Deliver Keynote at BSMA Annual Biotechnology Conference Oct 8-99
. Vet-Stem, Inc. Founder, Robert Harman, DVM, Invited as Inspirational Speaker for the 6th Annual After the Finish Line Charity Dinner10
. Nanounity Announces New Characterization Tools for the 2013 Microscopy & Microanalysis Annual Meeting in Indianapolis, August 4-811
. Bend Research Presents Drug Delivery Advancements at Controlled Release Society Annual Meeting